Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsStem CellsStem Cell TransplantationBlood Component RemovalHematopoietic Stem CellsCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionAdult Stem CellsRecurrenceCytophagocytosisCarmustineEmbryonic Stem CellsIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineCord Blood Stem Cell TransplantationHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationCell DifferentiationInfectionTime FactorsSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineBlood Cell CountRecombinant ProteinsLeukemiaFollow-Up StudiesAntineoplastic AgentsBone Marrow PurgingBlood CellsCytomegalovirus InfectionsLymphomaGraft vs Leukemia EffectProspective StudiesFatal OutcomeFeasibility StudiesMesenchymal Stem Cell TransplantationImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousLiver TransplantationLymphocyte DepletionT-LymphocytesBone MarrowLeukocytes, MononuclearCell SeparationHematologic DiseasesPluripotent Stem CellsHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaFlow Cytometry